2014
DOI: 10.1016/j.crad.2013.09.009
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
53
1
2

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 74 publications
(61 citation statements)
references
References 23 publications
5
53
1
2
Order By: Relevance
“…Subsequently, several groups have also published similar results from their retrospective experience [15][16][17][18][19][20][21][22] . The main limitations of these retrospective studies are that the patient cohorts were vastly heterogenous in terms of pathology treated, underlying liver disease, dosage and delivery of Y90, number of treatment sessions and time to measurement of hypertrophy.…”
Section: Y90 Radioembolizationsupporting
confidence: 60%
“…Subsequently, several groups have also published similar results from their retrospective experience [15][16][17][18][19][20][21][22] . The main limitations of these retrospective studies are that the patient cohorts were vastly heterogenous in terms of pathology treated, underlying liver disease, dosage and delivery of Y90, number of treatment sessions and time to measurement of hypertrophy.…”
Section: Y90 Radioembolizationsupporting
confidence: 60%
“…20 Nine studies, published between 2008 and 2014 were identified. [11][12][13][14][15][16][17][18][19] Three studies 11,12,15 were reported from the same centre with overlapping patient cohorts. Two studies 11,12 were excluded; and only the most recent (and largest) report 15 was included.…”
Section: Data Extractionmentioning
confidence: 99%
“…The study by Teo et al 16 was the first to report that HCC patients with hepatitis B experience a significantly greater degree of hypertrophy after SIRT (44.5%) compared to those with hepatitis C or alcoholic cirrhosis (7.7%). Although acknowledging the limitation of their small sample size, the authors postulated that the difference in hypertrophy was due to differences in underlying pathogenesis, with cirrhosis being a more important factor in patients with hepatitis C or alcoholic liver disease.…”
Section: Other Findingsmentioning
confidence: 99%
“…These effective diameters were measured in mm and defined as "volume-equivalent and area-equivalent diameters." The volume-equivalent diameter (D vol ) was calculated by inverting the sphere volume for-mula: D vol = (6 × V/π) ⅓ , whereby V = volume measurement (mm 3 ) and D vol = diameter (mm). To convert bidimensional measurements into unidimensional measurements, the surface area of a sphere was assumed.…”
Section: Data Managementmentioning
confidence: 99%